The State of Commercial Red Light Therapy in 2026: Market Trends Operators Need to Watch

The commercial red light therapy market has moved past the early-adopter phase. According to Grand View Research, the global market reached $533.8 million in 2025 and is projected to hit $587.5 million in 2026, with a compound annual growth rate of 9.8% through 2033. The B2B segment, covering medspas, wellness centers, hospitality facilities, and clinical practices, accounted for the largest revenue share in 2025. Six forces are reshaping the market right now: accelerating vertical adoption across new facility types, a more complex FDA regulatory landscape, private equity consolidation in adjacent wellness equipment categories, growing pressure for irradiance and methodology transparency, supply chain sourcing risk from white-label proliferation, and a tightening 12-to-24-month window for operators to establish market position before competition intensifies.

How Big Is the Commercial RLT Market in 2026, and How Fast Is It Growing?

The numbers tell a consistent story, even if different research firms measure the market at different scales. Grand View Research places the global red light therapy market at $533.8 million for 2025, growing to $587.5 million in 2026 at a 9.8% CAGR through 2033. The broader red light therapy beds segment shows steeper growth projections: Coherent Market Insights estimates the global beds market at $9.29 billion in 2026, reaching $19.56 billion by 2033 at a 13.2% CAGR. The bed-focused figure reflects a wider product scope that includes consumer formats, but both data sets point in the same direction.

B2B channels, covering medspas, wellness centers, rehabilitation centers, and hospitality facilities, still account for the largest revenue share in absolute terms. The B2C segment (home-use panels and portable devices) now carries the fastest CAGR in the forecast period, per Grand View Research, which reflects the consumer awareness wave feeding commercial demand downstream. North America holds a 44.6% global market share, while Asia Pacific is the fastest-growing region.

The broader wellness economy provides important context. According to the Global Wellness Institute's 2025 Wellness Economy Monitor, the global wellness economy reached $6.8 trillion in 2024 (up 7.9% from 2023), with a projected expansion to $9.8 trillion by 2029. The GWI specifically names infrared light therapy and photobiomodulation among the longevity and biohacking approaches now ubiquitous in fitness centers, spas, and resorts. RLT is not a niche add-on. It is becoming a standard facility offering.

Commercial RLT Market Size and Growth Projections 2025-2033

What Verticals Are Driving Commercial RLT Adoption?

Medspas are the anchor vertical. Consumer demand for non-surgical, non-injectable service options has grown at mid-to-high single-digit rates, according to data reviewed by the American Med Spa Association. Red light therapy slots in as a standalone service, a membership anchor, or an add-on to aesthetic treatments. The Fortune Business Insights light therapy market report notes that dermatology clinics and medical spas are primary buyers of commercial red light therapy devices, with red light holding approximately 34% of the total light therapy market share.

Hospitality is the fastest-growing commercial segment from a smaller base. Hotels and hospitality facilities are explicitly part of the B2B segment driving growth, per Grand View Research. The Global Wellness Institute notes that governments and hospitality brands are investing in therapeutic modalities to differentiate properties as wellness tourism expands. Properties such as Four Seasons, Fairmont, and Canyon Ranch have deployed commercial-grade red light therapy beds as premium amenity offerings, recognizing that equipment quality reflects on the property's overall wellness positioning.

Chiropractic, rehabilitation, and recovery-focused fitness facilities represent the next adoption wave. The Fortune Business Insights report cites rising demand from orthopedic and chiropractic centers as a specific growth driver. For these operators, the business case is direct: sessions run 10-20 minutes, setup is minimal, and the modality integrates into existing scheduling without adding staff. The Grand View Research data notes Precor partnered with Wellness USA in October 2024 to distribute RLT equipment across fitness facilities, spas, and hotels globally, signaling the mainstream fitness equipment channel treating RLT as a standard offering. Muscle recovery applications are projected to show the fastest CAGR among application segments through 2033.

Vertical Adoption Curve for Commercial Red Light Therapy 2024-2026

How Is the FDA Regulatory Landscape Shifting?

The FDA landscape for commercial red light therapy devices operates on two distinct tracks.

The first is the ILY product code (Infrared Lamp for Heating). Devices listed under ILY are Class II medical devices registered with the FDA. Registration means the manufacturer has submitted facility and device information to the FDA's device database, not that the device has undergone premarket review for specific clinical claims. ILY registration is the appropriate pathway for full-body commercial beds used for topical heating, temporary relief of minor muscle and joint pain and stiffness, temporary relief of minor arthritis pain, relaxation of muscle spasm, and temporary increase of local circulation. Body Balance System holds FDA Registration number 3010627475 under the ILY product code.

The second track is the OLH product code, covering phototherapy devices for skin conditions. OLH devices go through the 510(k) premarket notification pathway and can make specific claims tied to their cleared intended use, such as treatment of facial wrinkles or acne. The FDA's public 510(k) database shows a meaningful uptick in OLH filings, with multiple Shenzhen-based manufacturers receiving clearances in late 2025 and early 2026 (see K253400 and K252603).

For operators: the commercial market now contains devices at two regulatory tiers with different permitted claims frameworks. Neither designation is superior. The compliance requirement is that any device's registration or clearance number should be verifiable in the FDA's public database, and marketing claims should align with the device's regulatory classification. Operators should request the FDA establishment registration number and verify it directly. For more detail, see the BBS resource on what FDA registered actually means for red light therapy devices.

Why Is Consolidation Happening, and What Does It Mean for Buyers?

The medspa sector has entered an acknowledged consolidation cycle. According to data from the American Med Spa Association, private equity-backed platforms and management service organizations remained "highly active" in 2025, particularly in Florida, Texas, and California. Named platforms in active recapitalization include Empower Aesthetics (Shore Capital), Alpha Aesthetics (Thurston Group), and Advanced MedAesthetic Partners (Leon Capital). Greater than 90% of medspas remain independently owned, but PE is building regional scale through add-on acquisitions at the platform level.

When PE groups acquire medspa platforms, they standardize operations, including equipment suppliers. A platform that adopted a particular equipment brand during its independent phase carries that decision into every add-on acquisition. Operators who are potential acquisition targets should recognize that their equipment roster becomes part of the diligence story. Equipment with verifiable regulatory documentation, a demonstrable service track record, and a clear warranty structure is easier to underwrite than equipment from brands with thin operational histories.

Supply chain dynamics add another layer. A growing share of devices entering the market through direct-import channels originate from Chinese factories and are sold through white-label brands. This is not inherently a quality issue; many established brands source manufacturing offshore with strong specifications. The risk is when operators purchase devices with minimal documentation, warranties under 12 months (vs. the commercial standard of five years), and no verifiable FDA registration. For a deeper examination, see our guide on irradiance due diligence for commercial red light therapy buyers.

Where Is the Irradiance and Methodology Conversation Heading?

Irradiance transparency is one of the most active discussions in the commercial RLT channel right now, and it is being driven by a measurement methodology problem.

Broadband solar meters, which are low-cost handheld sensors used widely in the consumer and commercial RLT market, consistently overstate therapeutic irradiance relative to accredited laboratory measurement. Published data from ISO/IEC 17025-accredited photometric testing shows that broadband solar meter readings typically run 2.2 to 2.5 times higher than what the same device delivers when measured at therapeutic red and near-infrared wavelengths by a calibrated laboratory instrument traceable to NIST standards. This means a device advertised at "150 mW/cm²" based on a solar meter reading may deliver closer to 60-68 mW/cm² when measured with accredited lab instruments at therapeutic wavelengths. This is not a regulatory violation; irradiance measurement methodology is not currently standardized by FDA for ILY-class devices. But it creates a material information gap for buyers comparing equipment specifications.

The pressure for standardization is building from multiple directions. A subset of manufacturers has begun publishing ISO/IEC 17025-accredited lab reports for their devices. Peer review publications examining dose-response relationships in photobiomodulation are increasingly explicit about the need for standardized measurement protocols. NRTL (Nationally Recognized Testing Laboratory) certification bodies, including UL and ETL, provide electrical safety listings for commercial equipment but do not currently certify irradiance output. Some manufacturers voluntarily pursue NRTL listings as a signal of overall quality commitment. For operators who want to understand what the irradiance numbers in equipment specifications actually mean, our explainer on peer-reviewed research and commercial RLT standards provides context on how published PBM research actually characterizes dose.

For commercial operators, the practical implication is straightforward: ask any prospective equipment supplier how their irradiance figure was measured, at what distance, and whether the data comes from an accredited laboratory or a broadband solar meter. Contact irradiance at the point of client contact matters most. Body Balance System, for example, publishes 65 mW/cm² at contact for the OvationULT. The methodology behind any irradiance claim should be part of the procurement conversation for any commercial buyer. For guidance on what to ask, see how to add red light therapy to a medspa.

The broader photobiomodulation research community has also continued to accumulate evidence. Published research on the mechanism of action, specifically cytochrome c oxidase activation and ATP production in mitochondria, is well-established in the academic literature. For a primer on the cellular mechanism, see our resource on the photobiomodulation mechanism and how red light therapy works.

What Does the Next 12-24 Months Look Like for Commercial Operators?

Several forces are converging to make the next two years a consequential window for commercial operators considering red light therapy equipment.

On the demand side, the signals are consistent. According to the ISPA Foundation's 2025 Consumer Snapshot Study (PricewaterhouseCoopers, 1,000 U.S. respondents), 85% of spa-goers view visits as self-care, with younger consumers showing stronger acceptance of technology-assisted services. The North American spa industry generated $22.5 billion in revenue in 2024, per ISPA's 2025 U.S. Spa Industry Study as reported by Spas of America, its third consecutive year of expansion. Infrared and light therapy are specifically listed among longevity and biohacking-inspired services driving that growth.

On the supply side, the commercial equipment channel is becoming more crowded. Growing consumer demand and a relatively low barrier to importing and rebranding devices means new brands enter the market steadily. Many are consumer-grade products repositioned for commercial sale. For operators, the relevant questions go beyond specifications: Does the manufacturer have a commercial installation track record? Is the equipment backed by a multi-year commercial warranty? Does the manufacturer carry verifiable FDA registration?

The PE rollup activity in medspas reinforces this point. Equipment decisions are increasingly made at the platform level, not just the individual location. Operators building toward a multi-site model or positioning for a future sale should weigh equipment documentation, warranty structure, and manufacturer longevity alongside raw specifications. BBS, for example, has supported commercial installations for 13 years across properties including Bellagio, Aria, Four Seasons, Fairmont, and Canyon Ranch, and backs every OvationULT with a 5-year white-glove warranty.

Frequently Asked Questions

What is the size of the commercial red light therapy market in 2026?

According to Grand View Research, the global red light therapy market is projected to reach $587.5 million in 2026, up from $533.8 million in 2025. The broader red light therapy beds segment is estimated at $9.29 billion in 2026 by Coherent Market Insights, reflecting a wider product scope that includes all commercial and consumer bed formats globally.

What is the difference between FDA registration and FDA 510(k) premarket notification for red light therapy devices?

FDA registration means the manufacturer has submitted facility and device listing information to the FDA's establishment registration database. It does not involve premarket review of clinical claims. The 510(k) premarket notification pathway requires the manufacturer to demonstrate substantial equivalence to a predicate device and, if granted, permits specific clinical claims tied to the cleared intended use. The two designations serve different regulatory purposes and permit different marketing claims. For a detailed breakdown, see our guide on what FDA registered actually means.

Which verticals are growing fastest in commercial RLT adoption?

Medspas are the largest current adopter vertical. Hospitality (luxury hotels and resort spas) and performance-focused recovery facilities are showing the fastest growth rates from a smaller base. Chiropractic and rehabilitation practices represent a third wave of adoption, driven by growing patient demand for non-pharmaceutical modalities and an expanding base of published clinical evidence on photobiomodulation.

How should operators evaluate irradiance specifications when comparing commercial equipment?

Ask the manufacturer whether their irradiance figure was measured with a broadband solar meter or with a calibrated, accredited laboratory instrument (ISO/IEC 17025). Broadband solar meters consistently overstate therapeutic irradiance relative to accredited lab measurements by a factor of 2.2 to 2.5. Request documentation of the measurement distance and methodology. Contact irradiance at the point of client use is the most operationally relevant figure. View our irradiance due diligence guide for a structured evaluation framework.

What does PE consolidation in medspas mean for equipment purchasing decisions?

As private equity-backed platforms acquire multi-location medspa operators, equipment decisions that were previously made at the individual site level are increasingly made at the platform level. Operators positioning for acquisition or multi-site growth benefit from choosing equipment with verifiable regulatory documentation, commercial warranty coverage, and a manufacturer with a demonstrable multi-year service track record. These factors reduce diligence friction in a transaction process.

How long is a typical commercial red light therapy session?

Commercial red light therapy sessions typically run 10-20 minutes. This range allows operators to schedule approximately two clients per hour per unit, net of transition time, at a 15-minute session. Session length within the 10-20-minute range should be set based on the operator's protocol and the specific device's irradiance output. For specific revenue models, see our commercial red light therapy pricing guide.

Is the RLT market likely to face increased regulatory scrutiny?

The current trajectory suggests continued regulatory attention on claims standards more than on device registration requirements. The FDA has issued 510(k) clearances for an increasing number of OLH-code devices with specific cosmetic and dermatological claims. The ILY-code registration pathway remains the appropriate route for full-body commercial beds without 510(k) clearance. Operators and manufacturers who stay within their device's permitted claims scope are best positioned as oversight evolves.

Citations

• Grand View Research. "Red Light Therapy Market Size, Share and Industry Report, 2033." https://www.grandviewresearch.com/industry-analysis/red-light-therapy-market-report

• Coherent Market Insights. "Red Light Therapy Beds Market Size and Forecast, 2026-2033." https://www.coherentmarketinsights.com/industry-reports/red-light-therapy-beds-market

• Global Wellness Institute. "The Global Wellness Economy Hits a Record $6.8 Trillion and Is Forecast to Reach $9.8 Trillion by 2029." November 19, 2025. https://globalwellnessinstitute.org/press-room/press-releases/the-global-wellness-economy-hits-a-record-6-8-trillion-and-is-forecast-to-reach-9-8-trillion-by-2029/

• ISPA Foundation / International SPA Association. "Self-Care, Stress Relief and Tech Appeal: ISPA's 2025 Consumer Snapshot Study." June 26, 2025. https://experienceispa.com/press-releases/self-care-stress-relief-and-tech-appeal-ispas-2025-consumer-study-reveals-what-drives-spa-visits/

• American Med Spa Association / Xite. "Med Spa M&A and Private Sales: A Look Back at 2025 and What Lies Ahead." May 15, 2026. https://www.americanmedspa.org/news/med-spa-ma-and-private-sales-a-look-back-at-2025-and-what-lies-ahead/

• Fortune Business Insights. "Light Therapy Market Size, Industry Share, Forecast 2034." https://www.fortunebusinessinsights.com/light-therapy-market-106935